Search Results
Facet (Page)
Refine Your Search
Audiences
Content Formats
Sections
Video
About NHGRI
The Genomic Medicine Working Group explores and advises on issues related to the adoption of genomic medicine.
Research Funding
The Multi-Omics for Health and Disease Consortium aims to advance the application of multi-omic technologies to study health and disease in ancestrally diverse populations.
… Omics’ Production Center Zhiping Weng*, Anshul Kundaje, William Noble, Honghuang Lin, Jill Moore University of …
Educational Resources
NHGRI participates in the South By Southwest (SXSW) conference to help increase genomic literacy.
Media Advisory
On December 7, 2022, the National Human Genome Research Institute will host a webinar to discuss the key findings from a recently released Human Genetics & Genomics Workforce Survey Report.
News Release
NHGRI researchers and colleagues are calling for health disparities research that focuses on the microbiome.
News Release
Learn what happens when two genetic neighborhoods merge in brain tumor cells after a gene controlled by a gene-control switch turned on a cancer-growth gene.
… and becomes unmanageable. Read the article Flavahan, William A., et al. Insulator dysfunction and oncogene …
Staff
Dr. Chris Gunter is a senior advisor to the NHGRI director on genomics engagement.
… CL, Feingold EA, Felsenfeld AL, Kaufman DJ, Ostrander EA, Pavan WJ, Phillippy AM, Wise AL, Gupta Dayal J, Kish BJ, …
News Release
Dr. Gahl honored for his leading efforts to diagnose and treat individuals with rare and undiagnosed diseases.
File
… Program Coordinator (representing trainees) • Dr. Bill Pavan, Chief, Genetics Diseases Research Branch; Senior …
The Genomics Landscape
In the July 7, 2022 edition of The Genomics Landscape, NHGRI Director, Eric Green, M.D., Ph.D., emphasizes the importance of the Technology Transfer Office and its mission to manage all the legal negotiations that help to protect federally funded research from being unduly exploited, while also giving that research avenues to reach patients through the commercialization of promising advances.